Kidney And Liver Cancer Drug Raises High Blood Pressure Risk

Sorafenib, a new anti tumour (antineoplastic) drug marketed by Bayer under the brand Nexavar, and used to treat patients with advanced kidney or liver cancer, has been found to increase significantly the risk of developing high blood pressure.

More: continued here

Filed under: Cancer on January 29th, 2008